Von Willebrand disease (VWD) is inherited through changes in a single gene on chromosome 12 called the VWF gene, but the exact pattern of inheritance depends on the type. Most forms (type 1 and most type 2 subtypes) follow an autosomal dominant pattern, meaning a child only needs to inherit one altered copy of the gene from one parent to develop the condition. The more severe forms (type 3 and type 2N) are autosomal recessive, requiring altered copies from both parents. Because the gene sits on a non-sex chromosome, VWD affects men and women equally, occurring in up to 1% of the general population.
What the VWF Gene Does
The VWF gene carries the instructions for making von Willebrand factor, a protein that plays two critical roles in blood clotting. First, it helps platelets stick together and adhere to the walls of blood vessels at the site of a wound. Second, it acts as a carrier for another clotting protein called factor VIII, shuttling it to wherever a clot needs to form. Without enough functional von Willebrand factor, or when the protein is structurally abnormal, both of these processes break down and bleeding becomes harder to control.
Von Willebrand factor is produced inside the cells that line blood vessels and in bone marrow cells. A mutation in the VWF gene can reduce the amount of protein made, change its structure so it doesn’t work properly, or eliminate production altogether. Which of these happens determines the type of VWD a person has.
Type 1: Autosomal Dominant
Type 1 is the most common form, and it follows an autosomal dominant inheritance pattern. That means a person only needs one altered copy of the VWF gene to develop the condition. If one parent has type 1 VWD, each child has a 50% chance of inheriting the altered gene.
In type 1, the von Willebrand factor protein is structurally normal but produced in lower-than-usual quantities. However, the severity varies widely, even within the same family. Two people carrying the same genetic change can have noticeably different bleeding symptoms. This is what geneticists call variable expressivity, and it’s one reason type 1 VWD can go undiagnosed for years, particularly in people with mild cases.
Type 2: Mostly Dominant, With One Exception
Type 2 VWD involves a von Willebrand factor protein that is produced in normal or near-normal amounts but doesn’t function correctly. There are four subtypes (2A, 2B, 2M, and 2N), and their inheritance patterns differ.
Types 2A, 2B, and 2M are autosomal dominant, just like type 1. One altered gene copy from one parent is enough to cause the disease, and each child of an affected parent has a 50% chance of inheriting it. In these subtypes, the structural defect in the protein impairs its ability to help platelets clump together or bind to vessel walls.
Type 2N is the exception. It follows an autosomal recessive pattern, meaning a child must inherit an altered gene from both parents to be affected. Each parent carries one normal copy and one altered copy, and typically has no bleeding symptoms. When two carriers have a child, there’s a 25% chance that child will inherit both altered copies and develop the disease, a 50% chance the child will be a silent carrier like the parents, and a 25% chance the child will inherit two normal copies.
Type 2N is particularly tricky because it affects the part of the von Willebrand factor that carries factor VIII. This makes it look clinically similar to hemophilia A, a different bleeding disorder that is inherited through the X chromosome. People with type 2N VWD are sometimes misdiagnosed with hemophilia A. The key difference: hemophilia A is X-linked and primarily affects males, while type 2N VWD is autosomal recessive and affects both sexes equally. Genetic testing can distinguish between the two.
Type 3: Autosomal Recessive
Type 3 is the rarest and most severe form. It follows the same autosomal recessive pattern as type 2N. Both parents must carry one altered copy of the VWF gene, even though they usually have no significant symptoms themselves. A child who inherits the altered gene from both parents produces little to no von Willebrand factor, leading to serious bleeding problems.
The math is the same as type 2N: each pregnancy between two carriers has a 25% chance of producing an affected child. Because carriers often don’t know they carry an altered gene, type 3 VWD can appear to come out of nowhere in a family with no obvious bleeding history.
Why Severity Varies Even Within Families
One of the most confusing aspects of VWD inheritance is that carrying the same genetic change doesn’t guarantee the same symptoms. Several factors influence how the disease actually shows up in a given person.
Blood type is the most well-studied modifier. People with type O blood naturally have lower levels of von Willebrand factor. In a large study of over 1,100 healthy individuals, people with blood type O had an average von Willebrand factor level of 75 IU/dL, while those with blood type AB averaged 123 IU/dL. For someone who already carries a VWD gene variant, having type O blood can push their protein levels low enough to cause noticeable symptoms, while a family member with the same variant but blood type A or B might have levels that stay in a borderline-normal range. In fact, the normal range for von Willebrand factor in type O individuals extends below 50 IU/dL, the threshold commonly used to flag a potential problem, which can complicate diagnosis.
ABO blood group alone accounts for roughly 19% of the total variation in von Willebrand factor levels across the population. Race also plays a role: studies have found that white individuals tend to have lower levels than Black individuals, independent of blood type, accounting for about 7% of the variation. These non-genetic modifiers help explain why one sibling with type 1 VWD bleeds heavily during dental work while another with the same mutation barely notices anything unusual.
How Inheritance Differs From Hemophilia
People often compare VWD to hemophilia because both are inherited bleeding disorders, but the genetics are fundamentally different. Hemophilia A and B are X-linked, meaning the responsible gene sits on the X chromosome. This is why hemophilia overwhelmingly affects males: boys have only one X chromosome, so a single altered copy causes the disease. Girls, with two X chromosomes, are usually carriers but rarely affected.
VWD sits on chromosome 12, an autosome. It has nothing to do with sex chromosomes, which is why it shows up equally in males and females. This distinction matters for family planning. A father with type 1 VWD will pass his altered gene to roughly half of all his children, sons and daughters alike. A mother who carries hemophilia A, by contrast, will pass the altered X chromosome to about half her sons (who will be affected) and half her daughters (who will be carriers).
Genetic Testing and Carriers
Genetic testing can identify specific VWF mutations and is particularly useful in a few scenarios: confirming a type 2N diagnosis that might otherwise be confused with hemophilia A, identifying carriers in families with type 3 VWD, and clarifying ambiguous cases where blood-type effects make standard lab tests hard to interpret.
For autosomal recessive forms (type 3 and type 2N), carrier testing is especially relevant for family planning. Carriers produce enough von Willebrand factor from their one working gene copy to avoid symptoms, but they can pass the altered copy to their children. If both parents are carriers, prenatal or preconception genetic counseling can help them understand the odds for each pregnancy.